0001683168-22-005454.txt : 20220809 0001683168-22-005454.hdr.sgml : 20220809 20220809111919 ACCESSION NUMBER: 0001683168-22-005454 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220809 DATE AS OF CHANGE: 20220809 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANNAPHARMARX, INC. CENTRAL INDEX KEY: 0001081938 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274635140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-251016 FILM NUMBER: 221147100 BUSINESS ADDRESS: STREET 1: SUITE 3600 STREET 2: 888 3RD STREET SW CITY: CALGARY STATE: A0 ZIP: T2P 5C5 BUSINESS PHONE: 949-652-6838 MAIL ADDRESS: STREET 1: SUITE 3600 STREET 2: 888 3RD STREET SW CITY: CALGARY STATE: A0 ZIP: T2P 5C5 FORMER COMPANY: FORMER CONFORMED NAME: GOLDEN DRAGON HOLDING CO. DATE OF NAME CHANGE: 20110125 FORMER COMPANY: FORMER CONFORMED NAME: CCVG, INC. DATE OF NAME CHANGE: 20101117 FORMER COMPANY: FORMER CONFORMED NAME: CONCORD VENTURES, INC. DATE OF NAME CHANGE: 20071003 RW 1 canna_rw.htm REQUEST FOR WITHDRAWAL

August 9, 2022

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re:

CannaPharmaRX, Inc. (the “Company”)

Registration Statement on Form S-1/A, File No. 333-251016

Request for Withdrawal

Ladies and Gentleman:

The Company hereby applies for withdrawal of the Company’s Amended Registration Statement (File No. 333-251016) containing exhibits only on Form S-1/A submitted to the Securities and Exchange Commission (the “Commission”) on August 8, 2022 (the “Additional Exhibits Registration Statement”). The Company expressly does not with to withdraw any other filing made other than the August 8, 2022 filing including, but not limited to, any other Form S-1/A that has been declared effective or the Form S-1 which was declared effective.

Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Act”), the Company is withdrawing the Additional Exhibits Registration Statement, which has not been declared effective, because the Additional Exhibits Registration Statement was filed under an old file number. Since the Additional Exhibits Registration Statement was not declared effective by the Commission, no shares of common stock as described in the Additional Exhibits Registration Statement were sold.

The Company also requests in accordance with Rule 457(p) of the Act that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.

If you have any questions regarding the foregoing application for withdrawal, please do not hesitate to contact Joshua D. Brinen at Brinen & Associates, LLC, at 212-330-8151.


	Sincerely,

	CannaPharmaRX, Inc.

	By:		/s/ Domenic Colvin
			Domenic Colvin
			President and Chief Executive Officer

cc:	Joshua D. Brinen at Brinen & Associates, LLC